RXi announced the closing of a global license agreement for the therapeutic use of Samcyprone topical gel with Hapten Pharmaceuticals. Samcyprone is a proprietary immunomodulating topical gel with the ...
MEMPHIS, Tenn., Nov. 19, 2015 /PRNewswire/ -- Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now ...
The prognosis valve of tumor regression grade in the same ypStage patients after neoadjuvant treatment in locally advanced rectal cancer: Post-hoc analysis of a prospective trial. This is an ASCO ...
Non-invasive imaging of gene expression is important for both current and future clinical gene therapy trials, allowing definition of the location, magnitude and persistence of gene expression.
Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684. Of 62 patients with metastasis in a single lymph node bed ...
Hapten Sciences, Inc. is a privately held biopharmaceutical company based in Memphis, Tennessee. The company's mission is to identify and efficiently develop novel, early-stage products that will ...
Specific IgG antibodies directed against the spin-label nitroxide group present as a lipid hapten in single-compartment lipid vesicles have been visualized by using freeze-etch electron microscopy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results